445 related articles for article (PubMed ID: 7509439)
21. Direct effects of thymopentin (Arg-Lys-Asp-Val-Tyr) on cholinergic agonist-induced slow inactivation of nicotinic acetylcholine receptor function.
Ochoa EL; Li LA; Plummer A; McNamee MG
Mol Pharmacol; 1990 Dec; 38(6):863-71. PubMed ID: 2250665
[TBL] [Abstract][Full Text] [Related]
22. Photoactivatable agonist of the nicotinic acetylcholine receptor: potential probe to characterize the structural transitions of the acetylcholine binding site in different states of the receptor.
Chatrenet B; Kotzba-Hibert F; Mulle C; Changeux JP; Goeldner MP; Hirth C
Mol Pharmacol; 1992 Jun; 41(6):1100-6. PubMed ID: 1614412
[TBL] [Abstract][Full Text] [Related]
23. Desensitization of the nicotinic acetylcholine receptor by diisopropylfluorophosphate.
Eldefrawi ME; Schweizer G; Bakry NM; Valdes JJ
J Biochem Toxicol; 1988; 3():21-32. PubMed ID: 3236333
[TBL] [Abstract][Full Text] [Related]
24. d-Tubocurarine binding sites are located at alpha-gamma and alpha-delta subunit interfaces of the nicotinic acetylcholine receptor.
Pedersen SE; Cohen JB
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2785-9. PubMed ID: 2320589
[TBL] [Abstract][Full Text] [Related]
25. The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a noncompetitive antagonist.
Varanda WA; Aracava Y; Sherby SM; VanMeter WG; Eldefrawi ME; Albuquerque EX
Mol Pharmacol; 1985 Aug; 28(2):128-37. PubMed ID: 2410768
[TBL] [Abstract][Full Text] [Related]
26. Nicotinic receptor-elicited sodium flux in rat pheochromocytoma PC12 cells: effects of agonists, antagonists, and noncompetitive blockers.
Daly JW; Nishizawa Y; Edwards MW; Waters JA; Aronstam RS
Neurochem Res; 1991 Apr; 16(4):489-500. PubMed ID: 1922660
[TBL] [Abstract][Full Text] [Related]
27. Modulation of phencyclidine-sensitive ethidium binding to the Torpedo acetylcholine receptor: interaction of noncompetitive inhibitors with carbamylcholine and cobra alpha-toxin.
Valenzuela CF; Kerr JA; Duvvuri P; Johnson DA
Mol Pharmacol; 1992 Feb; 41(2):331-6. PubMed ID: 1538711
[TBL] [Abstract][Full Text] [Related]
28. Thymopoietin, a potent antagonist at nicotinic receptors in C2 muscle cell cultures.
Quik M; el-Bizri H; Audhya T; Goldstein G
Mol Pharmacol; 1991 Mar; 39(3):324-31. PubMed ID: 2005877
[TBL] [Abstract][Full Text] [Related]
29. Molecular effects of dimethylanatoxin on the peripheral nicotinic acetylcholine receptor.
Costa AC; Swanson KL; Aracava Y; Aronstam RS; Albuquerque EX
J Pharmacol Exp Ther; 1990 Feb; 252(2):507-16. PubMed ID: 1690291
[TBL] [Abstract][Full Text] [Related]
30. Interaction of a benzomorphan opiate with acetylcholinesterase and the nicotinic acetylcholine receptor.
Coleman BA; Michel L; Oswald R
Mol Pharmacol; 1987 Oct; 32(4):456-62. PubMed ID: 3670280
[TBL] [Abstract][Full Text] [Related]
31. Interactions of microtubule-active agents with nicotinic acetylcholine receptors. Relationship to their inhibition of catecholamine secretion by adrenal chromaffin cells.
McKay DB; Aronstam RS; Schneider AS
Mol Pharmacol; 1985 Jul; 28(1):10-6. PubMed ID: 2410767
[TBL] [Abstract][Full Text] [Related]
32. Structural characterization of alpha-bungarotoxin-binding proteins from Aplysia californica.
McLaughlin JT; Hawrot E
Mol Pharmacol; 1989 May; 35(5):593-8. PubMed ID: 2542757
[TBL] [Abstract][Full Text] [Related]
33. The binding characteristics of cholinergic sites in rabbit spermatozoa.
Young RJ; Laing JC
Mol Reprod Dev; 1991 Jan; 28(1):55-61. PubMed ID: 1994980
[TBL] [Abstract][Full Text] [Related]
34. Photoaffinity labeling of the acetylcholine binding sites on the nicotinic receptor by an aryldiazonium derivative.
Langenbuch-Cachat J; Bon C; Mulle C; Goeldner M; Hirth C; Changeux JP
Biochemistry; 1988 Apr; 27(7):2337-45. PubMed ID: 2454653
[TBL] [Abstract][Full Text] [Related]
35. Interactions of the thymic polypeptide hormone thymopoietin with neuronal nicotinic alpha-bungarotoxin binding sites and with muscle-type, but not ganglia-type, nicotinic acetylcholine receptor ligand-gated ion channels.
Lukas RJ; Audhya T; Goldstein G; Lucero L
Mol Pharmacol; 1990 Dec; 38(6):887-94. PubMed ID: 1701215
[TBL] [Abstract][Full Text] [Related]
36. Binding of semirigid nicotinic agonists to nicotinic and muscarinic receptors.
Spivak CE; Waters JA; Aronstam RS
Mol Pharmacol; 1989 Jul; 36(1):177-84. PubMed ID: 2747625
[TBL] [Abstract][Full Text] [Related]
37. Location of a polypeptide sequence within the alpha-subunit of the acetylcholine receptor containing the cholinergic binding site.
Oblas B; Singer RH; Boyd ND
Mol Pharmacol; 1986 Jun; 29(6):649-56. PubMed ID: 3713706
[TBL] [Abstract][Full Text] [Related]
38. Covalent labeling of the acetylcholine receptor from Torpedo electric tissue with the channel blocker [3H]triphenylmethylphosphonium by ultraviolet irradiation.
Muhn P; Hucho F
Biochemistry; 1983 Jan; 22(2):421-5. PubMed ID: 6297549
[TBL] [Abstract][Full Text] [Related]
39. Mapping of the acetylcholine binding site of the nicotinic acetylcholine receptor: [3H]nicotine as an agonist photoaffinity label.
Middleton RE; Cohen JB
Biochemistry; 1991 Jul; 30(28):6987-97. PubMed ID: 2069955
[TBL] [Abstract][Full Text] [Related]
40. Agonist-induced changes in the structure of the acetylcholine receptor M2 regions revealed by photoincorporation of an uncharged nicotinic noncompetitive antagonist.
White BH; Cohen JB
J Biol Chem; 1992 Aug; 267(22):15770-83. PubMed ID: 1639812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
